0 0 Paediatric Oncology Consultancy Limited 12169104 false 2024-09-01 2025-08-31 2025-08-31 The principal activity of the company is the provision of paediatric oncology consultancy. Digita Accounts Production Advanced 6.30.9574.0 true 12169104 2024-09-01 2025-08-31 12169104 2025-08-31 12169104 core:CurrentFinancialInstruments core:WithinOneYear 2025-08-31 12169104 bus:Micro-entities 2024-09-01 2025-08-31 12169104 bus:AuditExemptWithAccountantsReport 2024-09-01 2025-08-31 12169104 bus:FilletedAccounts 2024-09-01 2025-08-31 12169104 bus:SmallCompaniesRegimeForAccounts 2024-09-01 2025-08-31 12169104 bus:RegisteredOffice 2024-09-01 2025-08-31 12169104 bus:Director1 2024-09-01 2025-08-31 12169104 bus:PrivateLimitedCompanyLtd 2024-09-01 2025-08-31 12169104 countries:EnglandWales 2024-09-01 2025-08-31 12169104 2023-09-01 2024-08-31 12169104 2024-08-31 12169104 core:CurrentFinancialInstruments core:WithinOneYear 2024-08-31 xbrli:pure iso4217:GBP

Registration number: 12169104

Paediatric Oncology Consultancy Limited

Unaudited Financial Statements

for the Year Ended 31 August 2025

 

Paediatric Oncology Consultancy Limited

Statement of Financial Position as at 31 August 2025

2025
£

2024
£

Fixed assets

777

-

Current assets

114,816

98,037

Creditors: Amounts falling due within one year

(16,204)

(14,667)

Net current assets

98,612

83,370

Total assets less current liabilities

99,389

83,370

Accruals and deferred income

(3,073)

(1,573)

 

96,316

81,797

Capital and reserves

96,316

81,797

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
c/o Brebners
First Floor
1 Suffolk Way
Sevenoaks
Kent
TN13 1YL

2

Basis of Preparation

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

3

Staff numbers

The average number of persons employed by the company during the year was 0 (2024 - 0).

 

Paediatric Oncology Consultancy Limited

Statement of Financial Position as at 31 August 2025

For the financial year ending 31 August 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the micro entities regime and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Income Statement.

Approved and authorised by the Board on 28 August 2026 and signed on its behalf by:
 

.........................................
Dr Olga Slater
Director

Company registration number: 12169104